send link to app

Multiple Myeloma Management app for iPhone and iPad


4.8 ( 1008 ratings )
Medical Education
Developer: Med Learning Group
Free
Current version: 1.0, last update: 1 year ago
First release : 26 May 2023
App size: 89.88 Mb

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.